#Biosky

I'm here because @gilman.bsky.social. I haven't posted for 10 months. How does this place work?

Hello Michael! Where's the biotech party?

Akero’s $AKRO treatment for NASH falls short in cirrhosis study Liver fibrosis improvement 24% for EFX vs 14% placebo, not stat sig. But NASH resolution 63% vs 26%. More details and Akero comments in story below. www.statnews.com/2023/10/10/n...

The biotech scorecard for the third quarter: 15 stock-moving events to watch #biosky https://www.statnews.com/2023/07/03/biotech-scorecard-third-quarter-2023/

Happy Fourth! Eat a hot dog.

Wrote this back in December. Mastadon wasn't it. Post wasn't quite it. Maybe this is? And re-upping @adamfeuerstein.bsky.socialhttps://www.bloomberg.com/opinion/articles/2022-12-24/science-twitter-needs-a-new-home-and-mastodon-s-not-it

Science Twitter Needs a New Home

Covid energized, then fractured, the community. Elon Musk may have caused it to finally dissipate.

Data-DXd may turn out to benefit lung cancerpatients, but $AZN and Daiichi Sankyo disrespect the participants in their clinical trial by referring to side-effect related deaths as "Grade 5 events."

In an effort to bring biotech folks together on this platform, let’s try adding #biosky hashtag to all tweets. Hopefully, that will help us find each other. Please spread the word.

Woke up this morning to total Twitter lockdown. “Rate limit” messages only. Is complaining about Twitter any better or worse than complaining about flight cancellations? Onward, I guess.